Age at Entry Into Care, Timing of Antiretroviral Therapy Initiation, and 10-Year Mortality Among HIV-Seropositive Adults in the United States
about
An Illustration of Inverse Probability Weighting to Estimate Policy-Relevant Causal EffectsIncidence of AIDS-Defining Opportunistic Infections and Mortality during Antiretroviral Therapy in a Cohort of Adult HIV-Infected Individuals in Hanoi, 2007-2014Measurement Error and Environmental Epidemiology: A Policy PerspectiveTrends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up.Effect of immediate initiation of antiretroviral treatment in HIV-positive individuals aged 50 years or older.Immune recovery of middle-aged HIV patients following antiretroviral therapy: An observational cohort study.Comparing the Effectiveness of Dynamic Treatment Strategies Using Electronic Health Records: An Application of the Parametric g-Formula to Anemia Management Strategies.Immunosenescence and hurdles in the clinical management of older HIV-patients.Understanding the delay in starting antiretroviral therapy despite recent guidelines for HIV patients retained in care.Place Still Matters: Racial/Ethnic and Geographic Disparities in HIV Transmission and Disease Burden.Selective developmental alterations in The HIV-1 transgenic rat: Opportunities for diagnosis of pediatric HIV-1.Effect of immediate initiation of antiretroviral treatment on the risk of acquired HIV drug resistance.Sensitivity Analyses for Misclassification of Cause of Death in the Parametric G-Formula.Virologic failure and mortality in older ART initiators in a multisite Latin American and Caribbean Cohort.Achieving the fourth 90: healthy aging for people living with HIVEditorial Commentary:Age-Old Questions: When to Start Antiretroviral Therapy and in Whom?: Figure 1
P2860
Q28386534-0D2E335F-33B3-4CAA-A02B-5AF6B7325779Q28550534-496CDB98-9569-4CFF-935B-1CC1A9282AD5Q29248055-47280359-E2BA-4B75-93FC-CCAA5BD0719BQ33859987-1EA2D2CB-F955-4095-A7E0-FC4B734D19E2Q38660325-31502B87-531E-4018-AF20-6FAB7347D346Q38682437-BD2A4545-6F3F-4B02-9866-D919885FD019Q38754842-55BAFD6E-61B0-4BFB-947E-5A811DA3F3E8Q39170367-CC011F79-1672-42D7-98EC-6E7062F4CEC5Q39375427-645F3408-6BD8-46B6-9C1D-7355C9D9220CQ40503237-C05813AB-73E7-4A6D-BC37-B224D5C5D8D8Q40570704-11A734A8-C454-4010-9CEF-3BADC5D94C27Q47580916-7F3BBFD0-A381-4A5E-8F9F-D77D61514168Q50053522-CCCEA44A-E4ED-4DCA-B285-7C7CC9DF6069Q51760332-7291624F-BFDA-40F2-84ED-69563369B7AFQ56991795-45F5A525-6BDA-4967-B04D-3A3F864393A4Q57340295-B0BAEFCC-9D1F-49A2-AA5F-D140546A508B
P2860
Age at Entry Into Care, Timing of Antiretroviral Therapy Initiation, and 10-Year Mortality Among HIV-Seropositive Adults in the United States
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Age at Entry Into Care, Timing ...... ve Adults in the United States
@ast
Age at Entry Into Care, Timing ...... ve Adults in the United States
@en
Age at Entry Into Care, Timing ...... ve Adults in the United States
@nl
type
label
Age at Entry Into Care, Timing ...... ve Adults in the United States
@ast
Age at Entry Into Care, Timing ...... ve Adults in the United States
@en
Age at Entry Into Care, Timing ...... ve Adults in the United States
@nl
prefLabel
Age at Entry Into Care, Timing ...... ve Adults in the United States
@ast
Age at Entry Into Care, Timing ...... ve Adults in the United States
@en
Age at Entry Into Care, Timing ...... ve Adults in the United States
@nl
P2093
P2860
P356
P1476
Age at Entry Into Care, Timing ...... ve Adults in the United States
@en
P2093
Carolyn Williams
Centers for AIDS Research Network of Integrated Clinical Systems investigators
Daniel Westreich
Michael J Mugavero
Peter Hunt
Richard D Moore
Stephen R Cole
William C Mathews
P2860
P304
P356
10.1093/CID/CIV463
P407
P577
2015-06-16T00:00:00Z